Advertisement

Topics

Antibiotics Firms Cempra, Melinta Therapeutics Agree to Merger

11:08 EDT 9 Aug 2017 | Xconomy

Cempra plans to combine with Melinta Therapeutics, a merger that provides a new path forward for the Chapel Hill, NC, firm following the FDA’s surprising rejection of its lead drug late last year. Meanwhile, privately held Melinta, based in New Haven, CT, will gain a public stock listing through the deal as it prepares to […]

Original Article: Antibiotics Firms Cempra, Melinta Therapeutics Agree to Merger

NEXT ARTICLE

More From BioPortfolio on "Antibiotics Firms Cempra, Melinta Therapeutics Agree to Merger"

Quick Search
Advertisement
 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...